Pharmacologic Management of Glaucoma in Childhood
- 1 January 2007
- journal article
- review article
- Published by Springer Science and Business Media LLC in Pediatric Drugs
- Vol. 9 (2), 71-79
- https://doi.org/10.2165/00148581-200709020-00001
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Side-Effect Profile of Brimonidine Tartrate in ChildrenOphthalmology, 2005
- Analytic review of bimatoprost, latanoprost and travoprost in primary open angle glaucomaCurrent Medical Research and Opinion, 2005
- Central corneal thickness and its relationship to intraocular pressure in childrenOphthalmology, 2004
- Ocular and systemic side effects of brimonidine 0.2% eye drops (Alphagan®) in childrenEye, 2004
- Systemic Side Effects of Ophthalmic DropsClinical Pediatrics, 2004
- Hypotension and bradycardia in infants after the use of topical brimonidine and beta-blockersJournal of American Association for Pediatric Ophthalmology and Strabismus, 2003
- Efficacy of brimonidine 0.2% as adjunctive therapy for patients with glaucoma inadequately controlled with otherwise maximal medical therapyOphthalmology, 1999
- The efficacy and safety of the Dorzolamide—timolol combination versus the concomitant administration of its componentsOphthalmology, 1998
- Avoiding unsuspected respiratory side-effects of topical timolol with cardioselective or sympathomimetic agentsThe Lancet, 1995
- Congenital Glaucoma and Its InheritanceOphthalmologica, 1980